Willow Biosciences Completes Warrant Acceleration, Boasts $48.4 Million Cash Position
Willow Biosciences (TSX: WLLW) this morning provided an update on its acceleration of outstanding common share purchase warrants. The company
Read more
Willow Biosciences
Corporate Overview: Willow Biosciences Inc.
Willow Biosciences Inc. (TSX: WLLW) is a small-cap biotechnology company that produces high-purity, pharmaceutical-grade, plant-derived compounds that are the building blocks
Read more
Willow Biosciences Closes $28.8 Million Bought Deal Financing
Willow Biosciences (TSX: WLLW) on Friday closed their previously announced bought deal financing. The company raised a total of $28.8
Read more
Willow Biosciences: Jazz Pharma – GW Pharma Merger Has Positive Read-Through For Company
Last week’s announcement that Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has agreed to buy GW Pharmaceuticals (NASDAQ: GWPH) for US$7.2 billion
Read more
Willow Biosciences Increases Bought Deal Financing To $25.0 Million
Late last night, Willow Biosciences (TSX: WLLW) announced the upsizing of its bought deal financing following strong demand. The company
Read more
Willow Biosciences To Raise $20.0 Million In Bought Deal Financing
Willow Biosciences (TSX: WLLW) this evening announced that it will be conducting a bought deal financing. Lead by Eight Capital
Read more
THC Production From Yeast – The Daily Dive feat Trevor Peters of Willow Biosciences
Today on the Daily Dive, we sit down with Trevor Peters, CEO of Willow Biosciences (TSX: WLLW). Trevor joins us
Read more
Willow Biosciences Looks To Launch Biosynthesized THC In Canadian Market
Willow Biosciences (TSX: WLLW) this morning had a major announcement, with the company announcing that it has advanced its work
Read more
The Future Of Cannabinoid Manufacturing? – The Daily Dive feat Trevor Peters of Willow Biosciences
Joining us for the first time on The Daily Dive today is that of Trevor Peters, CEO of Willow Biosciences
Read more
Willow Biosciences Announces First Commercial Production Of CBG To Occur In Q1 2021
Willow Biosciences (TSX: WLLW) announced major news this morning in that it has advanced its commercialization plan for biosynthesized CBG
Read more